Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

0
Player Avatar johnandmarie123 (32.69) Submitted: 1/26/2011 1:12:49 PM : Outperform Start Price: $4.82 SVA Score: -65.07

potential in the China drug market

Featured Broker Partners


Advertisement